Nifty
Sensex
:
:
23997.35
77562.90
873.70 (3.78%)
2946.32 (3.95%)

Pharmaceuticals & Drugs

Rating :
49/99

BSE: 540737 | NSE: Not Listed

486.45
08-Apr-2026
  • Open
  • High
  • Low
  • Previous Close
  •  481.1
  •  514
  •  469.65
  •  469.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6543
  •  3174838
  •  514
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 624.49
  • 34.54
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 646.92
  • N/A
  • 3.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.80%
  • 1.13%
  • 24.95%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.48
  • 17.22
  • 5.93

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.21
  • 23.50
  • 10.84

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.84
  • 18.83
  • 15.02

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 34.50
  • 36.15

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 3.06
  • 3.76

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 24.94
  • 27.68

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
21.11
27.05
-21.96%
30.31
32.33
-6.25%
24.67
24.78
-0.44%
24.43
37.33
-34.56%
Expenses
14.38
17.15
-16.15%
20.70
21.02
-1.52%
17.37
16.66
4.26%
14.56
20.40
-28.63%
EBITDA
6.73
9.90
-32.02%
9.62
11.31
-14.94%
7.30
8.12
-10.10%
9.88
16.93
-41.64%
EBIDTM
31.89%
36.59%
31.73%
34.98%
29.58%
32.78%
40.43%
45.35%
Other Income
0.66
0.71
-7.04%
0.69
0.19
263.16%
0.66
0.55
20.00%
2.29
1.32
73.48%
Interest
0.74
0.39
89.74%
1.01
0.44
129.55%
0.94
0.32
193.75%
0.97
0.15
546.67%
Depreciation
2.67
2.70
-1.11%
2.59
2.42
7.02%
2.42
2.02
19.80%
2.42
1.86
30.11%
PBT
3.98
7.53
-47.14%
6.71
8.64
-22.34%
4.60
6.33
-27.33%
8.77
16.25
-46.03%
Tax
0.89
2.10
-57.62%
1.76
2.23
-21.08%
1.15
1.68
-31.55%
2.18
3.66
-40.44%
PAT
3.09
5.42
-42.99%
4.96
6.41
-22.62%
3.45
4.65
-25.81%
6.59
12.59
-47.66%
PATM
14.65%
20.05%
16.35%
19.81%
13.97%
18.76%
26.97%
33.73%
EPS
2.41
4.22
-42.89%
3.86
4.99
-22.65%
2.68
3.62
-25.97%
5.13
10.01
-48.75%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 20
Mar 19
Net Sales
100.52
108.60
125.90
64.02
35.31
Net Sales Growth
-17.26%
-13.74%
96.66%
81.31%
 
Cost Of Goods Sold
33.49
35.87
57.45
37.92
18.50
Gross Profit
67.03
72.72
68.45
26.10
16.82
GP Margin
66.68%
66.96%
54.37%
40.77%
47.64%
Total Expenditure
67.01
69.38
84.09
51.50
26.57
Power & Fuel Cost
-
7.89
6.39
1.54
0.85
% Of Sales
-
7.27%
5.08%
2.41%
2.41%
Employee Cost
-
10.12
8.41
2.90
1.63
% Of Sales
-
9.32%
6.68%
4.53%
4.62%
Manufacturing Exp.
-
7.35
4.82
0.70
0.56
% Of Sales
-
6.77%
3.83%
1.09%
1.59%
General & Admin Exp.
-
2.72
2.48
6.93
3.69
% Of Sales
-
2.50%
1.97%
10.82%
10.45%
Selling & Distn. Exp.
-
4.77
3.95
1.23
1.18
% Of Sales
-
4.39%
3.14%
1.92%
3.34%
Miscellaneous Exp.
-
0.66
0.60
0.28
0.17
% Of Sales
-
0.61%
0.48%
0.44%
0.48%
EBITDA
33.53
39.22
41.81
12.52
8.74
EBITDA Margin
33.36%
36.11%
33.21%
19.56%
24.75%
Other Income
4.30
3.73
3.07
3.91
1.17
Interest
3.66
2.11
0.61
0.54
0.20
Depreciation
10.10
9.57
6.11
2.29
1.04
PBT
24.06
31.27
38.16
13.59
8.67
Tax
5.98
8.20
10.05
3.12
2.43
Tax Rate
24.85%
26.22%
26.34%
22.96%
28.03%
PAT
18.09
23.07
28.11
10.47
6.24
PAT before Minority Interest
18.09
23.07
28.11
10.47
6.24
Minority Interest
0.00
0.00
0.00
0.00
0.00
PAT Margin
18.00%
21.24%
22.33%
16.35%
17.67%
PAT Growth
-37.77%
-17.93%
168.48%
67.79%
 
EPS
14.13
18.02
21.96
8.18
4.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 20
Mar 19
Shareholder's Funds
145.16
122.10
42.20
33.82
Share Capital
12.84
12.84
8.97
8.97
Total Reserves
132.32
109.25
33.23
24.85
Non-Current Liabilities
30.60
30.16
2.65
0.73
Secured Loans
29.48
29.12
0.04
0.24
Unsecured Loans
0.00
0.00
2.15
0.00
Long Term Provisions
0.46
0.33
0.18
0.16
Current Liabilities
24.23
25.96
10.38
6.79
Trade Payables
5.97
8.19
4.52
3.90
Other Current Liabilities
10.17
8.30
0.20
0.18
Short Term Borrowings
0.02
0.71
2.07
0.33
Short Term Provisions
8.07
8.76
3.59
2.39
Total Liabilities
199.99
178.22
55.27
41.34
Net Block
95.00
80.55
20.14
14.50
Gross Block
128.34
105.23
28.81
21.05
Accumulated Depreciation
33.34
24.68
8.68
6.55
Non Current Assets
114.37
100.73
21.46
15.53
Capital Work in Progress
8.78
16.92
0.00
0.00
Non Current Investment
0.08
0.08
0.07
0.05
Long Term Loans & Adv.
10.50
3.18
1.06
0.72
Other Non Current Assets
0.00
0.01
0.20
0.27
Current Assets
85.62
77.48
33.82
25.81
Current Investments
18.26
4.66
3.00
4.00
Inventories
22.02
24.99
6.41
6.51
Sundry Debtors
22.27
20.33
17.79
9.72
Cash & Bank
10.03
16.26
2.33
1.00
Other Current Assets
13.04
0.80
0.00
0.00
Short Term Loans & Adv.
11.88
10.43
4.29
4.58
Net Current Assets
61.39
51.52
23.44
19.02
Total Assets
199.99
178.21
55.28
41.34

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 20
Mar 19
Cash From Operating Activity
30.66
30.45
4.59
-5.22
PBT
31.27
38.16
13.59
8.67
Adjustment
11.18
5.89
-3.66
-0.35
Changes in Working Capital
-1.73
-5.47
-5.34
-13.53
Cash after chg. in Working capital
40.72
38.59
4.59
-5.22
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-10.05
-8.14
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-35.66
-33.01
-2.91
-0.08
Net Fixed Assets
-14.97
-97.03
-4.07
Net Investments
-13.60
2.28
-3.05
Others
-7.09
61.74
4.21
Cash from Financing Activity
-1.09
9.84
-0.48
-0.18
Net Cash Inflow / Outflow
-6.08
7.28
1.20
-5.47
Opening Cash & Equivalents
15.85
8.66
1.13
6.46
Closing Cash & Equivalent
9.95
15.85
2.33
0.99

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 20
Mar 19
Book Value (Rs.)
113.07
95.07
35.14
33.80
ROA
12.20%
24.08%
21.67%
15.08%
ROE
17.26%
34.22%
27.55%
18.43%
ROCE
19.53%
37.81%
34.79%
25.66%
Fixed Asset Turnover
0.95
1.93
2.57
1.68
Receivable days
69.81
53.79
78.42
100.48
Inventory Days
77.02
44.31
36.84
67.29
Payable days
72.01
40.38
32.14
54.62
Cash Conversion Cycle
74.82
57.72
83.12
113.16
Total Debt/Equity
0.26
0.30
0.11
0.02
Interest Cover
15.84
63.85
26.05
43.45

News Update:


  • Shree Ganesh Remed. - Quarterly Results
    24th Jan 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.